The Clinical Influence of Developing a Sustainable Cardiac Surgery Service to Reduce the Burden of Rheumatic Heart Disease in Sub-Saharan Africa
Launched by HELSE NORD-TRØNDELAG HF · Sep 15, 2020
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving cardiac surgery services for people with rheumatic heart disease in Ethiopia. The goal is to understand how effective cardiac surgery is in helping patients recover and live better lives, especially in a low-income country where such services are often limited. The study will compare the outcomes of patients who receive surgery to those who do not, as well as look into how well patients are managed with blood-thinning medications after their surgery.
To participate in this trial, individuals must be having cardiac surgery due to rheumatic heart disease at the Black Lion University Hospital during the study period. Anyone who is not able or willing to provide consent will not be included. Participants can expect to receive quality care and attention, as the study aims to enhance the local healthcare system while ensuring that patients receive the best possible treatment for their condition. This is an exciting opportunity to contribute to important research that could improve heart health for many people in the region.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cardiac surgery due to rheumatic heart disease at the governmental Black Lion University Hospital during the bi-directional programme of education, training and Research to establish Cardiac surgery service
- Exclusion Criteria:
- • Not willing or able to provide written informed consent
About Helse Nord Trøndelag Hf
Helse Nord-Trøndelag HF is a prominent healthcare provider in Norway, dedicated to delivering high-quality medical services and advancing clinical research. As a regional health enterprise, it plays a pivotal role in the integration of health services, focusing on patient-centered care, innovation, and collaboration with academic institutions. The organization is committed to enhancing health outcomes through rigorous clinical trials, contributing to the development of new therapies and improving treatment protocols. With a strong emphasis on ethical standards and scientific integrity, Helse Nord-Trøndelag HF is at the forefront of fostering a robust research environment that benefits both patients and the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Trondheim, , Norway
Bergen, , Norway
Addis Ababa, , Ethiopia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials